EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Immunopathogenesis of Human T-Cell Leukemia Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: Recent Perspectives

Mineki Saito, Charles R M Bangham

Leukemia Research and Treatment · 2012

DOI: 10.1155/2012/259045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leukemia Research and Treatment, 2012. Verfasst von Mineki Saito und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Okinawa 903-0215, Japan. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Wellcome Trust, Japan Society for the Promotion of Science.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human T-cell leukemia virus type-1 (HTLV-1) is a replication-competent human retrovirus associated with two distinct types of disease only in a minority of infected individuals: the malignancy known as adult T-cell leukemia (ATL) and a chronic inflammatory central nervous system disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HAM/TSP is a chronic progressive myelopathy characterized by spastic paraparesis, sphincter dysfunction, and mild sensory disturbance in the lower extremities. Although the factors that cause these different manifestations of HTLV-1 infection are not fully understood, accumulating evidence from host population genetics, viral genetics, DNA expression microarrays, and assays of lymphocyte function suggests that complex virus-host interactions and the host immune response play an important role in the pathogenesis of HAM/TSP. Especially, the efficiency of an individual's cytotoxic T-cell (CTL) response to HTLV-1 limits the HTLV-1 proviral load and the risk of HAM/TSP. This paper focuses on the recent advances in HAM/TSP research with the aim to identify the precise mechanisms of disease, in order to develop effective treatment and prevention.

Autor:innen und Institutionen

  • Department of Immunology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Okinawa 903-0215, Japan.

Förderung

  • Wellcome Trust
  • Japan Society for the Promotion of Science

Zitieren

APA

Saito, M., & Bangham, C. R. (2012). Immunopathogenesis of Human T-Cell Leukemia Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: Recent Perspectives. Leukemia Research and Treatment. https://doi.org/10.1155/2012/259045

Vancouver

Saito M, Bangham CR. Immunopathogenesis of Human T-Cell Leukemia Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: Recent Perspectives. Leukemia Research and Treatment. 2012. doi:10.1155/2012/259045

BibTeX
@article{Saito2012,
  author = {Saito, Mineki and Bangham, Charles R M},
  title = {Immunopathogenesis of Human T-Cell Leukemia Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: Recent Perspectives},
  journal = {Leukemia Research and Treatment},
  year = {2012},
  doi = {10.1155/2012/259045}
}
Kostenlos starten →